Presidential Address to The American Association of Immunologists
暂无分享,去创建一个
[1] R. Atkins,et al. Early cellular events in a systemic graft-vs.-host reaction. II. Autoradiographic estimates of the frequency of donor lymphocytes which respond to each Ag-B-determined antigenic complex , 1975, The Journal of experimental medicine.
[2] M. Bevan,et al. Hypothesis: why do so many lymphocytes respond to major histocompatibility antigens? , 1977, Cellular immunology.
[3] P. Fink,et al. The Influence of Thymus H‐2 Antigens on the Specificity of Maturing Killer and Helper Cells , 1978, Immunological reviews.
[4] R. Zinkernagel,et al. On the thymus in the differentiation of "H-2 self-recognition" by T cells: evidence for dual recognition? , 1978, The Journal of experimental medicine.
[5] L. Sherman. Influence of the major histocompatibility complex on the repertoire of allospecific cytolytic T lymphocytes , 1982, The Journal of experimental medicine.
[6] L. Hood,et al. The murine T-cell receptor uses a limited repertoire of expressed Vβ gene segments , 1985, Nature.
[7] J. Yagüe,et al. The T cell repertoire may be biased in favor of MHC recognition , 1986, Cell.
[8] P. Marrack,et al. T cell tolerance by clonal elimination in the thymus , 1987, Cell.
[9] J. Sprent,et al. T Cell Selection in the Thymus , 1988, Immunological reviews.
[10] R. Zinkernagel,et al. Positive selection of CD4+ thymocytes controlled by MHC class II gene products , 1988, Nature.
[11] H. Boehmer,et al. Positive selection of antigen-specific T cells in thymus by restricting MHC molecules , 1988, Nature.
[12] A. Heimberger,et al. Induction by antigen of intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. , 1990, Science.
[13] J. Bluestone,et al. Peptide-induced conformational changes in class I heavy chains alter major histocompatibility complex recognition , 1992, The Journal of experimental medicine.
[14] J. D. Dal Porto,et al. Major histocompatibility complex conformational epitopes are peptide specific , 1992, The Journal of experimental medicine.
[15] M. Davis,et al. Analysis of a T cell receptor gene as a target of the somatic hypermutation mechanism , 1992, The Journal of experimental medicine.
[16] L. Sherman,et al. The molecular basis of allorecognition. , 1993, Annual review of immunology.
[17] P. Ohashi,et al. Positive and negative thymocyte selection induced by different concentrations of a single peptide. , 1994, Science.
[18] Kristin A. Hogquist,et al. T cell receptor antagonist peptides induce positive selection , 1994, Cell.
[19] L. Pease,et al. Peptide-induced conformational changes in class I molecules. Direct detection by flow cytometry. , 1994, Journal of immunology.
[20] S. Tonegawa,et al. Evidence for a differential avidity model of T cell selection in the thymus , 1994, Cell.
[21] A. Lobashevsky,et al. Selective T cell receptor Vbeta gene usage by alloreactive T cells responding to defined HLA-DR alleles. , 1996, Transplantation.
[22] D. Fremont,et al. Structures of an MHC Class II Molecule with Covalently Bound Single Peptides , 1996, Science.
[23] Robyn L. Stanfield,et al. An αβ T Cell Receptor Structure at 2.5 Å and Its Orientation in the TCR-MHC Complex , 1996, Science.
[24] P. Marrack,et al. The Repertoire of T Cells Shaped by a Single MHC/Peptide Ligand , 1996, Cell.
[25] Partho Ghosh,et al. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2 , 1996, Nature.
[26] Mark I. Greene,et al. Control of MHC Restriction by TCR Vα CDR1 and CDR2 , 1996, Science.
[27] P. Marrack,et al. T cells can be activated by peptides that are unrelated in sequence to their selecting peptide. , 1997, Immunity.
[28] L R Pease,et al. Alphabeta T cell receptor interactions with syngeneic and allogeneic ligands: affinity measurements and crystallization. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[29] J. Zerrahn,et al. The MHC Reactivity of the T Cell Repertoire Prior to Positive and Negative Selection , 1997, Cell.
[30] D. Wiley,et al. Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. , 1998, Immunity.
[31] W A Hendrickson,et al. Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. , 1998, Immunity.
[32] N. Gascoigne,et al. Polymorphism within a TCRAV family influences the repertoire through class I/II restriction. , 1998, Journal of immunology.
[33] P. A. Peterson,et al. Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. , 1998, Immunity.
[34] A. Rudensky,et al. Subtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[35] I. Wilson. Perspectives: protein structure. Class-conscious TCR? , 1999, Science.
[36] P. Marrack,et al. An inverse relationship between T cell receptor affinity and antigen dose during CD4(+) T cell responses in vivo and in vitro. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[37] A. Smolyar,et al. The crystal structure of a T cell receptor in complex with peptide and MHC class II. , 1999, Science.
[38] B M Baker,et al. Four A6-TCR/peptide/HLA-A2 structures that generate very different T cell signals are nearly identical. , 1999, Immunity.
[39] E. Unanue,et al. Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. , 2000, Immunity.
[40] K. Garcia,et al. A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. , 2000, Science.
[41] D. Wiley,et al. Structure of a covalently stabilized complex of a human αβ T‐cell receptor, influenza HA peptide and MHC class II molecule, HLA‐DR1 , 2000, The EMBO journal.
[42] E. Palmer,et al. Quantifying the Frequency of Alloreactive T Cells In Vivo: New Answers to an Old Question1 , 2001, The Journal of Immunology.
[43] E. Joly,et al. Genetic control of peripheral TCRAV usage by representation in the preselection repertoire and MHC allele-specific overselection. , 2001, International immunology.